122 related articles for article (PubMed ID: 2491929)
1. Comparative efficacy of nonheated and heat-treated factor IX complex concentrate in treatment of hemophiliacs with inhibitors.
Schwartz RS; Ewing NP; Gorenc TJ; Spero JA
Am J Hematol; 1989 Jan; 30(1):22-6. PubMed ID: 2491929
[TBL] [Abstract][Full Text] [Related]
2. Failure of factor VIII inhibitor bypassing activity (Feiba) to secure haemostasis in haemophilic patients with antibodies.
Parry DH; Bloom AL
J Clin Pathol; 1978 Nov; 31(11):1102-5. PubMed ID: 739057
[TBL] [Abstract][Full Text] [Related]
3. Inhibitor antibodies to factor VIII and factor IX: management.
Lusher JM
Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
[TBL] [Abstract][Full Text] [Related]
4. The effect of activated prothrombin-complex concentrate (FEIBA) on joint and muscle bleeding in patients with hemophilia A and antibodies to factor VIII. A double-blind clinical trial.
Sjamsoedin LJ; Heijnen L; Mauser-Bunschoten EP; van Geijlswijk JL; van Houwelingen H; van Asten P; Sixma JJ
N Engl J Med; 1981 Sep; 305(13):717-21. PubMed ID: 6790990
[TBL] [Abstract][Full Text] [Related]
5. [Articular and muscular hemorrhages in hemophilia A with anti-factor VIII antibodies. Treatment with selected batches of PPSB (factor IX concentrate)].
Verroust F; Moussard C; Allain JP
Presse Med; 1985 May; 14(19):1073-6. PubMed ID: 3158962
[TBL] [Abstract][Full Text] [Related]
6. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
Abildgaard CF; Britton M; Harrison J
J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of hemophiliacs with inhibitors].
Fujimaki M
Rinsho Ketsueki; 1985 Jul; 26(7):1059-68. PubMed ID: 3932719
[No Abstract] [Full Text] [Related]
8. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
9. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
McGrath KM; Thomas KB; Herrington RW; Turner PJ; Taylor L; Ekert H; Schiff P; Gust ID
Med J Aust; 1985 Jul; 143(1):11-3. PubMed ID: 2989666
[TBL] [Abstract][Full Text] [Related]
10. Intramuscular hemorrhage in hemophiliacs with inhibitors. A medical emergency.
Scranton PE; Hasiba U; Gorenc TJ
JAMA; 1979 May; 241(19):2028-30. PubMed ID: 430796
[TBL] [Abstract][Full Text] [Related]
11. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of factor VIII or prothrombin complex concentrate infusions in children with haemophilia and antibodies to factor VIII.
Ekert H; Price DA; Lane JL; Dean FL
Aust N Z J Med; 1979 Jun; 9(3):241-4. PubMed ID: 288389
[TBL] [Abstract][Full Text] [Related]
13. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
Schimpf K; Schwarz P; Kunschak M
Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
[No Abstract] [Full Text] [Related]
14. Incidence of immune responses following 102 infusions of autoplex in 18 hemophilic patients with antibody to factor VIII.
Laurian Y; Girma JP; Lambert T; Meyer D; Larrieu MJ
Blood; 1984 Feb; 63(2):457-62. PubMed ID: 6419798
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII inhibitors in hemophilia.
Mariani G
Bilt Hematol Transfuz; 1979; 7(1):3-41. PubMed ID: 121880
[No Abstract] [Full Text] [Related]
16. Apheresis.
Nilsson IM; Freiburghaus C
Adv Exp Med Biol; 1995; 386():175-84. PubMed ID: 8851026
[TBL] [Abstract][Full Text] [Related]
17. [Importance of PPSB fraction in the treatment of hemophilia A with antibodies against factor VIII].
Hrubisková K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(4):672-82. PubMed ID: 6162735
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of patients with hemophilia A having antibodies to factor VIII].
Lopaciuk S; Ziemski JM
Acta Haematol Pol; 1979; 10(2):115-22. PubMed ID: 474044
[TBL] [Abstract][Full Text] [Related]
19. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
Buchanan GR; Kevy SV
Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
[TBL] [Abstract][Full Text] [Related]
20. Early experience with the use of anti-inhibitor coagulant complex to treat bleeding in hemophiliacs with inhibitors to factor VIII.
Kantrowitz JL; Lee ML; McClure DA; Kingdon HS; Thomas WR
Clin Ther; 1987; 9(4):405-19. PubMed ID: 3111706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
